Literature DB >> 8487179

Treatment of anterior chamber fibrin following cataract surgery with tissue plasminogen activator.

G R Lesser1, R H Osher, D Whipple, G W Abrams, R J Cionni.   

Abstract

Three patients who developed anterior chamber fibrinous exudates after cataract surgery were treated with tissue plasminogen activator injected into the anterior chamber. There was prompt dissolution of the fibrinous exudates and no observed complications. When fibrinous exudates occur in high-risk patients after cataract surgery, tissue plasminogen activator provides an excellent means of clearing the fibrin.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8487179     DOI: 10.1016/s0886-3350(13)80961-3

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  3 in total

1.  Outcome of lens aspiration and intraocular lens implantation in children aged 5 years and under.

Authors:  L Cassidy; J Rahi; K Nischal; I Russell-Eggitt; D Taylor
Journal:  Br J Ophthalmol       Date:  2001-05       Impact factor: 4.638

Review 2.  Alteplase. A reappraisal of its pharmacology and therapeutic use in vascular disorders other than acute myocardial infarction.

Authors:  A J Wagstaff; J C Gillis; K L Goa
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

3.  Intraocular Lens Opacification following Intracameral Injection of Recombinant Tissue Plasminogen Activator to Treat Inflammatory Membranes after Cataract Surgery.

Authors:  Simon S M Fung; Evripidis Sykakis; Niaz M Islam; Hadi J Zambarakji; Ramin Khoramnia; Gerd U Auffarth; Dipak N Parmar
Journal:  J Ophthalmol       Date:  2015-03-18       Impact factor: 1.909

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.